Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients
- PMID: 23110735
- DOI: 10.1111/j.1537-2995.2012.03739.x
Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients
Comment in
-
Leucoreduction of blood components: an effective way to increase blood safety?Blood Transfus. 2016 May;14(2):214-27. doi: 10.2450/2015.0154-15. Epub 2015 Dec 16. Blood Transfus. 2016. PMID: 26710353 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical